Changes in expression of the mouse homologues of KIAA genes after subchronic methamphetamine treatment

Annals of the New York Academy of Sciences

Volumn 1025, Issue , 2004, Pages 92-101

  Yamamoto, H ^a   Imai, K ^b   Takamatsu, Y ^a   Kamegaya, E ^a   Hara, Y ^b,c   Shimada, K ^b,c   Yamamoto, T ^a,d   Shen, H W ^a   Hagino, Y ^a   Kobayashi, H ^a   Ide, S ^a   Sora, I ^a,e   Koga, H ^b,c   Ikeda, K ^a  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b Chiba Industry Advancement Center   (Japan)

^c KAZUSA DNA RESEARCH INSTITUTE   (Japan)

^d YOKOHAMA CITY UNIVERSITY   (Japan)

^e TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

cDNA microarray; Hippocampus; Methamphetamine; Per2; SCOP

Indexed keywords

BRAIN PROTEIN; METHAMPHETAMINE; PER2 PROTEIN; PROTEIN SCOP; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CIRCADIAN RHYTHM; CONFERENCE PAPER; CONTROLLED STUDY; DNA HYBRIDIZATION; DNA MICROARRAY; DRUG DEPENDENCE; GENE; GENE EXPRESSION; HIPPOCAMPUS; IMMUNOBLOTTING; KIAA GENE; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

ANIMALIA;

EID: 10444251859     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1316.012     Document Type: Conference Paper

References (23)

1. BROWN, J.M. et al. 2001. Regulation of the vesicular monoamine transporter-2: a novel mechanism for cocaine and other psychostimulants. J. Pharmacol. Exp. Ther. 296: 762-767.
2. ROTHMAN, R.B. et al. 2001. Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse 39: 32-41.
3. DELONGCHAMP, R.R., A.J. HARRIS & J.F. BOWYER. 2003. A statistical approach in using cDNA array analysis to determine modest changes in gene expression in several brain regions after neurotoxic insult. Ann. N.Y. Acad. Sci. 993: 363-376; discussion 387-393.
4. JAYANTHI, S. et al. 2002. Methamphetamine causes coordinate regulation of Src, Cas, Crk, and the Jun N-terminal kinase-Jun pathway. Mol. Pharmacol. 61: 1124-1131.
5. KRASNOVA, I.N. et al. 2002. cDNA array analysis of gene expression profiles in the striata of wild-type and Cu/Zn superoxide dismutase transgenic mice treated with neurotoxic doses of amphetamine. FASEB J. 16: 1379-1388.
6. XIE, T. et al. 2002. Changes in gene expression linked to methamphetamine-induced dopaminergic neurotoxicity. J. Neurosci. 2: 274-283.
7. PERSICO, A.M. et al. 1993. Brain transcription factor expression: effects of acute and chronic amphetamine and injection stress. Brain Res. Mol. Brain Res. 20: 91-100.
8. PERSICO, A.M. et al. 1995. Brain transcription factor gene expression, neurotransmitter levels, and novelty response behaviors: alterations during rat amphetamine withdrawal and following chronic injection stress. Synapse 19: 212-227.
9. UJIKE, H. et al. 2002. Gene expression related to synaptogenesis, neuritogenesis, and MAP kinase in behavioral sensitization to psychostimulants. Ann. N.Y. Acad. Sci. 965: 55-67.
10. SOKOLOV, B.P., O.O. POLESSKAYA & G.R. UHL. 2003. Mouse brain gene expression changes after acute and chronic amphetamine. J. Neurochem. 84: 244-252
11. NOMURA, N. et al. 1994, Prediction of the coding sequences of unidentifed human genes. I. The coding sequences of 40 new genes (KIAA0001 - KIAA0040) deduced by analysis of randomly sampled cDNA clones from human immature myeloid cell line KG-1. DNA Res. 1(Suppl.): 47-56.
12. BENES, V. & M. MUCKENTHALER. 2003. Standardization of protocols in cDNA microarray analysis. Trends Biochem. Sci. 28: 244-249.
13. HARA, Y. et al. 2003. High-throughput production of recombinant antigens for mouse KIAA proteins in Escherichia coli: computational allocation of possible antigenic regions, and construction of expression plasmids of glutathione-S-transferase-fused antigens by an in vitro recombination-assisted method. DNA Res. 10: 129-136.
14. CHOE, E.-S. et al. 2002. Amphetamine increases phosphorylation of extracellular signal-regulated kinase and transcription factors in the rat striatum via group I metabotropic glutamate receptors. Neuropsychopharmacology 27: 565-575.
15. DUNLAP, J.C. 1999. Molecular bases for circadian clocks. Cell 96: 271-290.
16. ANDRETIC, R., S. CHANEY & J. HIRSH. 1999. Requirement of circadian genes for cocaine sensitization in Drosophila. Science 285: 1066-1068.
17. ABARCA, C., U. ALBRECHT & R. SPANAGEL. 2002. Cocaine sensitization and reward are under the influence of circadian genes and rhythm. Proc. Natl. Acad. Sci. USA 99: 9026-9030.
18. SHIMIZU, K. et al. 1999. SCOP, a novel gene product expressed in a circadian manner in rat suprachiasmatic nucleus. FEBS Lett. 458: 363-369
19. SHIMIZU, K. et al. 2003. Suprachiasmatic nucleus circadian oscillatory protein, a novel binding partner of K-Ras in the membrane rafts, negatively regulates MAPK pathway. J. Biol. Chem. 278: 14920-14925.
20. ATKINS, C.M. et al. 1998. The MAPK cascade is required for mammalian associative learning. Nat. Neurosci. 1: 602-609.
21. BRAMBILLA, R. et al. 1997. A role for the Ras signalling pathway in synaptic transmission and long-term memory. Nature 390: 281-286.
22. VOREL, S.R. et al. 2001. Relapse to cocaine-seeking after hippocampal theta burst stimulation. Relapse to cocaine-seeking after hippocampal theta burst stimulation. Science 292: 1175-1178.
23. VOLKOW, N.D. et al. 2002. Role of dopamine, the frontal cortex and memory circuits in drug addiction: insight from imaging studies. Neurobiol. Learn. Mem. 78: 610-624.